VERAGENE

VERAgene is the only non-invasive prenatal test that can simultaneously screen for aneuploidies, microdeletions and single gene diseases. The diseases screened by VERAgene are often severe with significant impact on the quality of life. These genetic diseases exhibit symptoms such as congenital anomalies, development delays, hearing loss, blindness, metabolic disorders, etc.
VERAgene can detect trisomies of chromosomes 21, 18, 13, aneuploidies of X and Y chromosomes, DiGeorge syndrome, 1p36 deletion syndrome, Smith-Magenis syndrome and Wolf-Hirschhorn syndrome. VERAgene targets 500 mutations to screen for 50 monogenic disorders. By combining detection of aneuploidies and microdeletions with the screening of monogenic disorders, VERAgene provides a comprehensive picture of the pregnancy using a single test. 
VERAgene can be carried out as early as the 10th week of pregnancy
For more information, clarifications or concerns do contact us on (+356) 7979 7910 or at novagia@hotmail.com